For people living with cystic fibrosis or COPD, clearing mucus from the lungs is daily work. The most established tools, such as chest physiotherapy and inflatable oscillation vests, help, but they can be bulky, loud and tied to a machine on the floor. The Pneuma Band explores a different approach: a slim belt around the diaphragm that uses ultrasound to work on the mucus itself, with an optional bass shaker for the deeper oscillation that existing vests provide.
Research prototype. The Pneuma Band is in early development. It is not FDA-cleared, has not been clinically tested, and is not available for sale. Nothing on this page is medical advice. If you use airway clearance therapy, keep following the plan from your care team.
The idea
The Pneuma Band wraps around the lower chest, just over the diaphragm. It combines two kinds of vibration that do very different jobs:
- Ultrasonic layer. Small piezoelectric elements set into the band emit ultrasonic frequencies, far above the range of hearing. They are not meant to shake the chest. The aim is to act on the mucus directly, loosening and thinning it so it is easier to clear.
- Low-frequency layer (optional). A compact bass shaker, also called a tactile transducer, can be added to deliver the gentle, low-frequency chest oscillation that established airway clearance vests rely on.
The science it builds on
Chest wall oscillation. High-frequency chest wall oscillation (HFCWO) is an established airway clearance therapy. A vest rapidly squeezes and releases the chest, loosening mucus so it can be cleared. It is widely used in cystic fibrosis and is also used in COPD and bronchiectasis. The evidence for COPD is smaller than for cystic fibrosis, but early studies reported good tolerability, less mucus and improved symptoms. This is the role of the optional bass shaker.
Ultrasound and mucus. This is much newer ground. Researchers have begun building and testing ultrasonic transducer arrays with cystic fibrosis in mind, and therapeutic ultrasound has been trialled for sinus problems in people with cystic fibrosis, where thick mucus is also a problem. So far, though, there is little direct evidence on whether ultrasound delivered through the chest can change mucus in the lungs. Answering that question is the core of this project.
How it is designed
- Piezo array. Ultrasonic piezoelectric elements are spaced around the inner face of the band. Arranged as an array, they can potentially be steered to focus energy toward a target area rather than spreading it evenly.
- Tunable output. Frequency, intensity and pulse pattern are adjustable, so the right settings can be found through testing.
- Optional bass shaker module. Adds low-frequency chest oscillation, the approach with the strongest existing evidence, alongside the ultrasound.
- Wearable form. A soft, adjustable belt instead of a full vest, aimed at sessions that fit more easily into daily life.
Open questions we are working on
- Getting ultrasound to the mucus. Air in the lungs reflects almost all ultrasound that reaches it. That is why lung ultrasound imaging is difficult, and it is the biggest physics challenge for this design. We need to learn how much energy can reach mucus in the airways, and where.
- Effect on mucus. Lab tests on mucus-like fluids and sputum samples come first, to measure whether and how ultrasound changes thickness and stickiness.
- Safety limits. Ultrasound can heat tissue and, at higher intensities, cause cavitation. Output has to stay within medical safety limits, set with clinicians before any human testing.
- Working together. Whether the ultrasonic and low-frequency layers work better together than either one alone.
- Comfort and battery life. Good contact with the skin across different body shapes, and enough runtime for a full session on one charge.
Future directions: solving the air problem
Ultrasound bounces off the lungs because of a mismatch in acoustic impedance, which is a material's density times its speed of sound. Soft tissue and air differ by a factor of thousands, so nearly all the energy reflects where they meet. Changing what fills the lungs changes that boundary, and that opens up some research paths:
- Liquid-filled lungs. Perfluorocarbons (PFCs) are dense, oxygen-carrying liquids whose acoustic impedance is close to that of tissue. In a lung filled with PFC, ultrasound could travel through the airways instead of bouncing off them. PFC liquid ventilation has only been studied in intensive care, with patients sedated and on a ventilator, and it has never become an approved therapy. A combined PFC-and-ultrasound treatment would be a hospital procedure, not an at-home routine, but it is the most direct physical answer to the reflection problem.
- Why breathing gases don't fix it. Swapping air for heliox or nitrox doesn't help the ultrasound. Every gas is far too thin to carry it, and heliox is even lighter than air. Heliox has a different benefit: it flows more easily through narrowed airways, which is why it is sometimes used during severe asthma and COPD flare-ups. It could help air move past mucus during coughing.
- Ultrasound on the medicine, not the lung. Ultrasonic and vibrating-mesh nebulizers already turn mucus-thinning treatments, such as hypertonic saline, into a mist that reaches deep airways. Pairing the band with a nebulizer routine could combine chemical thinning inside the lungs with the bass shaker's mechanical clearance from outside.
- Sound through the airway. Low frequencies travel through air far better than ultrasound does. Existing airway clearance devices vibrate the air column inside the airways as you breathe out. A future version of the band could sync its chest oscillation with that kind of breathing device.
Concept: the resonant rebreather
The most ambitious version of this idea pairs the band with a breathing circuit, so sound reaches the lungs from both sides at once: through the chest wall from the band, and down the airway from a mouthpiece. The two would be kept in sync, so the oscillations meet in phase and reinforce each other instead of cancelling out.
- How it would work. A mouthpiece connects to a closed breathing loop, a rebreather, with a small acoustic driver that sends low-frequency pressure waves down the airway. Sensors on the band and in the loop measure both waves, and a controller adjusts the timing so the inside and outside oscillations stay locked together.
- Tuning to the lungs. The respiratory system has its own natural resonant frequency, which clinicians already measure with a lung function test called forced oscillation. In healthy adults it is roughly 8 to 12 Hz, and it shifts with disease. Tuning both waves to each person's measured resonance could deliver the most movement for the least force.
- Why a rebreather. A closed loop recirculates the breathing gas instead of venting it with every breath. That makes it practical to use special gas mixes like heliox, which is expensive, and it keeps the acoustic path sealed and predictable. The loop needs a carbon dioxide scrubber to stay breathable. The deep eutectic solvents we've written about are one candidate material for that scrubber.
- What it would take. Rebreathers carry real risks: carbon dioxide buildup and low oxygen can both be dangerous, so the loop would need continuous gas monitoring and automatic safety cutoffs. A system like this would be developed and tested under clinical supervision long before anyone used it on their own.
Why it matters to us
Stewardship starts with the people closest to us. Airway clearance is a lifelong routine for many people, and every hour it costs is an hour taken from school, work and family. If a lighter, quieter tool can make that routine easier, it is worth building carefully and testing honestly.
The Pneuma Band is one of two resonance belts in development. Its companion, the Osteon Band, uses low-frequency vibration on the lower back.
